Egetis Therapeutics AB (publ)
STO:EGTX

Watchlist Manager
Egetis Therapeutics AB (publ) Logo
Egetis Therapeutics AB (publ)
STO:EGTX
Watchlist
Price: 4.62 SEK 3.47%
Market Cap: 1.8B SEK

Intrinsic Value

The intrinsic value of one EGTX stock under the Base Case scenario is hidden SEK. Compared to the current market price of 4.62 SEK, Egetis Therapeutics AB (publ) is hidden .

EGTX Intrinsic Value
HIDDEN
Show
Base Case Scenario

Valuation History
Egetis Therapeutics AB (publ)

Intrinsic Value History
Dive into the past to invest in the future

EGTX looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if EGTX is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about EGTX?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is EGTX valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Egetis Therapeutics AB (publ).

Explain Valuation
Compare EGTX to
Custom
Choose any stock to compare

Fundamental Analysis

EGTX Profitability Score
Profitability Due Diligence

Loading...
Loading...
Loading...
Loading...
Profitability
Score

EGTX Solvency Score
Solvency Due Diligence

Loading...
Loading...
Loading...
Loading...
Solvency
Score
Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about EGTX?
Bearish
Neutral
Bullish
Efficiency

Free Cash Flow Analysis
Egetis Therapeutics AB (publ)

Last Value
3-Years Average
FCF Margin
Conversion Rate

Wall St
Price Targets

EGTX Price Targets Summary
Egetis Therapeutics AB (publ)

Wall Street analysts forecast EGTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EGTX is 13.97 SEK with a low forecast of 10.1 SEK and a high forecast of 17.85 SEK.

Lowest
Price Target
10.1 SEK
119% Upside
Average
Price Target
13.97 SEK
202% Upside
Highest
Price Target
17.85 SEK
286% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Egetis Therapeutics AB (publ)
does not pay dividends
Shareholder Yield

Current shareholder yield for EGTX is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one EGTX stock?

The intrinsic value of one EGTX stock under the Base Case scenario is hidden SEK.

Is EGTX stock undervalued or overvalued?

Compared to the current market price of 4.62 SEK, Egetis Therapeutics AB (publ) is hidden .

Back to Top